This study evaluated (CKPV)₂, a dimeric peptide based on alpha-MSH's C-terminal KPV sequence, for its ability to combat endotoxin-induced inflammation. In vitro, (CKPV)₂ inhibited TNF-α production by human blood cells stimulated with LPS, matching the efficacy of NDP-α-MSH while outperforming monomeric KPV. In vivo, it markedly reduced circulating TNF-α after LPS injection and, in a peritonitis model, restored ultrafiltrate volume while reducing TNF-α and nitric oxide levels in both plasma and peritoneal fluid. The results support (CKPV)₂ as a promising anti-inflammatory therapeutic.
Gatti, Stefano; Carlin, Andrea; Sordi, Andrea; Leonardi, Patrizia; Colombo, Gualtiero; Fassati, Luigi R; Lipton, James M; Catania, Anna